22 results
Thumbnail

D2.151 - HZ-Y030, an Oral STAT6 Degrader, Attenuates Type 2 Inflammation in Preclinical Asthma Models

Thumbnail

D2.152 - Clinical and functional characteristics of patients with suspected epoxy resin-related occupational asthma

Thumbnail

D2.155 - Mapping the Architecture and Spectrum of the Cough Hypersensitivity Questionnaire Across Respiratory Diseases

Thumbnail

D2.158 - Circulating 1-methylnicotinamide can predict the treatment response of dupilumab in adult asthma

Thumbnail

D2.157 - Clinical remission with tezepelumab in severe asthma: prevalence and predictors in a real-world multicentre study

Thumbnail

D2.159 - Idiopathic Chronic Eosinophilic Pneumonia: A Case Series

Thumbnail

D2.160 - Household Overcrowding and Number of Siblings as Risk Factors for Uncontrolled Asthma in Inner-City Children

Thumbnail

D2.161 - Exploring the Early-Life Interplay Between Respiratory Health and Neurodevelopmental disorders

Thumbnail

D3.357 - Revealing an Underlying Inborn Error of Immunity in Pediatric Granulomatous Disease: A Case of STAT1 Loss-of-Function–Associated Mendelian Susceptibility to Mycobacterial Disease after BCG Vaccination

Thumbnail

D3.361 - Pulmonary Embolism in a Patient with Hyper IgE (Job) Syndrome Associated with Genetic Thrombophilia: A Rare Case

Thumbnail

D3.362 - Ulcerative Colitis Developing in an Immunodeficiency Patient with CD19 Gene Mutation: A Case Report

Thumbnail

D3.363 - Systemic Lupus Erythematosus in a Patient with Hyper IgM Syndrome

Thumbnail

D3.366 - Experience With Berotralstat In The First Turkish Patients

Thumbnail

D3.367 - Clinical and immunological heterogeneity of 22q11.2 deletion syndrome in children from the Republic of Moldova

Thumbnail

D3.419 - Efficacy, safety, and remission outcomes of omalizumab in elderly patients with severe allergic asthma: a subgroup analysis by age of onset

Thumbnail

D3.420 - Real-world epidemiologic characteristics of patients treated with dupilumab for type 2 inflammatory indications: a single-center retrospective cohort study

Thumbnail

D3.422 - Dupilumab in children with multimorbid atopic phenotype: therapy efficacy, safety and biomarker changes

Thumbnail

D3.424 - Retrospective Analysis of Self-Administration of Biologic Treatments for Severe Asthma and Chronic Urticaria

Thumbnail

D3.426 - Predicting response to omalizumab in patients with chronic spontaneous urticaria: The first results of the global multicenter UCARE SCOPUS project

Thumbnail

D3.427 - Challenging the paradigm: Use of omalizumab in refractory angioedema in a 2-year-old child